Delivery Order SPE2DB25D3017-SPE2DB25FVHZY
Award Date
5/7/25
Potential Completion Date
5/29/25
Potential Value
$5.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of XOLAIR 150 MG/ML SYRINGE. The contract is a firm fixed-price delivery order with a ceiling value of $5,064.24 and a period of performance through May 27, 2025. The contract is not set aside and was awarded on May 5, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,519.16, is for the delivery of the pharmaceutical product XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML. The contract is a firm fixed-price delivery order with a completion date of May 20, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order, valued at $12,327.20, is for the supply of XOLAIR 300 MG/2 ML SYRINGE 2ML, a specialty pharmaceutical product. Amerisourcebergen Drug Corp is the prime contractor and has an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2025....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $40,044.00, is for the delivery of XOLAIR 150 MG/1.2 ML POWDER VLS, a prescription medication. The contract is a firm fixed-price delivery order without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XOLAIR 150 MG/ML syringes, a medication used to treat certain medical conditions. The contract has a firm fixed price of $4,322.04 and a completion date of May 22, 2025. This contract is not designated as a set-aside and was competitively awarded. Amerisourcebergen Drug...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,881.36, is for the delivery of Xolair 150 mg/mL syringes. It is a firm-fixed-price delivery order contract with a period of performance through May 9, 2025. The contract is not set-aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award is for the delivery of XOLAIR 150 MG/ML SYRINGEML to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $5,042.38, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of May 16, 2025....
This federal contract award, valued at $5,762.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XOLAIR 150 MG/ML SYRINGEML, a medication, with a performance period through May 7, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,762.72 contract is for the supply of 150 mg/mL syringes of the biologic medication Xolair. The order has a performance period through May 14, 2025. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for federal...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $40,044.00, is for the delivery of Xolair 150 mg/1.2 ml powder vials, a medication used to treat certain respiratory conditions. The contract is a firm fixed-price, non-set-aside award with a period of performance through May 7, 2025. AmerisourceBergen Drug Corp holds a substantial...